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DObjectives: Our study examines the outcomes of the Ross procedure in a cohort of 212 patients prospectively
followed with clinical and echocardiographic assessments.
Methods: Patients’ mean age was 34  9 years; 66% were men and 82% had congenital aortic valve disease.
The median follow-up was 13.8 years. Patients who had reoperations continued to be followed and entered into
the survival analysis.
Results: There was 1 operative death as well as 9 late deaths (3 in patients who no longer had the Ross). Survival
at 20 years was 93.6% and similar to the general population matched for age and sex. Fifteen patients required
reoperations on the pulmonary autograft (4 repairs and 11 replacements), 8 on the pulmonary homograft, and
4 other cardiac procedures. At 20 years the freedom from reoperation on the pulmonary autograft was 81.8%
and on the pulmonary homograft was 92.7%, and in both was 79.9%. Preoperative aortic insufficiency, aortic
annulus diameter 15 mm/m2, and being a man were associated with increased risk of reoperation on the
pulmonary autograft. Twenty-six patients developed aortic insufficiency greater than mild and 25 patients
developed pulmonary homograft dysfunction (defined as moderate or severe insufficiency and/or peak systolic
gradient of>40 mm Hg). At 20 years the freedom from aortic insufficiency was 62.6% and freedom from
pulmonary valve dysfunction was 53.5%.
Conclusions: Survival after the Ross procedure in this cohort was similar to the general population. Dilated
aortic annulus and aortic insufficiency were associated with increased risk of developing aortic insufficiency.
Pulmonary homograft dysfunction was common at 20 years. (J Thorac Cardiovasc Surg 2014;147:85-94)The usefulness of the Ross procedure remains controver-
sial.1-10 Some surgeons believe it is an excellent option in
children or young adults regardless of the aortic valve
pathology,8-10 whereas others have shown worrisome
failure rates during the second decade of follow-up,4 partic-
ularly in patients with incompetent bicuspid aortic valve.5-7
Dilation of the neo-aortic root was thought to be the
principal cause of failure of the pulmonary autograft11,12
but further experience with reoperations indicated that
degeneration of the neo-aortic valve was a common
pathologic finding regardless of the technique used for its
transfer into the aortic position.5,6,13 Thus, performance of
aortic valve sparing operations to preserve the pulmonary
autograft is not always feasible in patients who developed
aortic insufficiency (AI).6,13,14 Moreover, the durability of
aortic valve sparing operations after the Ross procedure
remains unknown. Finally, not only the pulmonary
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The Journal of Thoracic and Cused to replace the pulmonary valve fails, compounding
the problem of reoperations in patients with failed Ross
procedure.14,15
Our study examines the outcomes of the Ross procedure
in a cohort of patients who have been prospectively
followed with periodical echocardiographic assessment of
valve function to further elucidate the late outcomes of
this controversial operation to treat aortic valve disease in
young adults.
METHODS
From 1990 to 2004, 212 consecutive patients underwent the Ross
operation performed by 1 surgeon and were prospectively followed
annually during the first decade and biennially thereafter. Echocardiogra-
phy was used for periodical assessment of valve function and aortic root
dimensions. Table 1 shows the clinical profile of all patients. The operative
techniques used in these patients were described in a previous article.6
Basically, the pulmonary autograft was secured in the aortic position using
amodified subcoronary implantation or aortic root inclusion in 104 patients
and as a freestanding neo-aortic root in 108 patients. The decision to use an
inclusion technique (subcoronary or root inclusion) or root replacement
was largely dependent on the pathology of the aortic root, sizes of the native
aortic root and pulmonary root, and anatomy of the coronary arteries. Thus,
patients with small aortic root, previous aortic valve surgery, or anomalous
right coronary artery orifice (the orifice was too close to the aortic annulus
for subcoronary implantation) often had aortic root replacement, whereas
those with normal or dilated aortic roots had inclusion techniques. The
noncoronary aortic sinus was always opened down to the level of the
annulus when inclusion techniques were used to improve exposure and
facilitate implantation of the pulmonary autograft. The diameters of the
annulus and sinotubular junction of the pulmonary and aortic roots were
recorded and surgical adjustments were made before implantation of the
pulmonary valve in the aortic position if the aortic annulus was greaterardiovascular Surgery c Volume 147, Number 1 85
Abbreviation and Acronym
AI ¼ aortic insufficiency
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Dthan the pulmonary annulus by more than 2 to 3 mm.6-16 The techniques
used to reduce the aortic annulus have been previously published.16
Follow-up
The referring cardiologists followed the patients and provided annual
clinical and echocardiographic data. The echocardiographic study was
repeated in our hospital whenever the report indicated moderate or severe
AI or pulmonary valve dysfunction (moderate or severe insufficiency or a
peak systolic gradient>40 mm Hg). For this study, the follow-up was
closed on November 1, 2012, and was complete in 202 patients. The
remaining 9 patients had partial echocardiographic follow-up because we
could not get studies due to geographic location. The median duration of
the clinical follow-up was 13.8 years; interquartile range (IQR), 10.6 to
17.1 years; and was 100% complete. The median duration of the echocar-
diographic follow-up was 13.2 years; IQR, 9.1 to 16.1 years; 9 patients did
not have a study during the past 1 to 3 years. AI and pulmonary insuffi-
ciency was initially graded based on color flow Doppler,17 and since
2003 the guidelines of the American Society of Echocardiography were
adopted.18 Patients who had any reoperation continued to be followed
and were included into the survival analysis to compare survival of Ross
patients with that of the general population matched for sex and age.Statistical Analysis
All variables in Tables 1 and 2 were examined. Variables with rare
frequencies (<2.5% or <20 events) were reported in the descriptive
statistics but were either collapsed (when possible) or excluded from all
risk factor analyses (ie, timing of surgery, previous cardiac operations,
angina pectoris, and endocarditis). Data are presented as means with
standard deviations, median with IQR, and frequencies, as appropriate.
Potential cut points for increased risk of outcomes based on aortic
annulus size were tested in logistic regression models. From these
models, receiver operating characteristic curves were created in which
the sensitivity and specificity of all potential cut points was evaluated to
identify the cut point with the most accurate segregation of patients by
outcome. Additionally, probability function derived from the logistic
regression model was graphed to visually represent the change in
probability of outcome based on aortic annulus size. Life tables from the
Province of Ontario from 2000-200219 were used to estimate 20-year
survival of the patient cohort according to age and sex distribution.
Freedom from time-dependent outcomes was modeled in parametric
survival models (using maximum likelihood estimates to resolve risk)
that divide risk over time in up to 3 distinct phases of risk (early, constant,
and late) using standard mathematical algorithms from the HAZARD
procedure (http://www.clevelandclinic.org/heartcenter/hazard). The para-
metric survival models were combined to obtain prevalence of mutually
exclusive events (reoperation all causes and mortality all causes). All
associations between freedom from outcomes and potential predictors
were first screened in univariable models. Associations between patient
and surgical characteristics and outcomes were included in a bootstrap
bagging algorithm (500 resamples). Variables with high reliability
(>50%) (defined as percent of resample in which a given variable is
selected) were then included in a multivariable parametric survival
regression model with backward selection of variables to obtain a final
model. All risk factors analyses were performed using a unified phase of
risk given the limited number of event in some phases of risk. Because
of the low number of events for most models, the multivariable models
have limited reliability and we used instead univariable associations.
Mean imputation was used to account for missing variables. Progression86 The Journal of Thoracic and Cardiovascular Surgeof aortic sinus dimension over time was modeled in linear regression
models adjusted for repeated measures over time through a compound
symmetry covariance structure. All statistical analyses were performed
using SAS version 9.3 (SAS Institute Inc, Cary, NC).
RESULTS
Patients’ Survival
There was 1 operative death as well as 9 late deaths. The
only operative death was due to myocardial infarction and it
is depicted in Figure 1, A. Three of the late deaths occurred
in patients who no longer had the pulmonary autograft in the
aortic position. The causes of late deaths were valve-related
in 3 patients (sudden death in all 3 patients) and noncardiac
related in 6 patients. The survival of the entire cohort of
Ross patients, including those who had reoperations for
any cause is shown Figure 1, A, and it is only slightly lower
than the survival of the general population matched for
sex and age (odds ratio for death in cohort vs population,
1.7; 95% confidence interval [CI], 0.6-4.5; P ¼ .37).
Figure 1, B, shows survival free from reoperation on the
pulmonary autograft or homograft and the competing risk
of death and any reoperation. Survival of the entire cohort
at various times intervals is shown in Table 2.
Thromboembolic Complications
Two patients experienced a stroke with complete re-
covery and 2 experienced a transient ischemic attack. The
freedom from this complication at various times intervals
is shown in Table 2.
Infective Endocarditis
Four patients developed infective endocarditis of the
pulmonary homograft and none in the pulmonary autograft.
Two patients were successfully treated with antibiotics
alone and 2 required surgery. One of the patients who
required surgery also had moderate AI and both the pulmo-
nary homograft and autograft were replaced at the same
operation. The second patient had pulmonary homograft
replacement and tricuspid valve repair. In addition, 1 of 2
patients who developed endocarditis needed pulmonary
valve replacement 4 years later because of severe pulmo-
nary insufficiency. The freedom from infective endocarditis
at various time intervals is shown in Table 2.
Hemorrhagic Complications
There was no major hemorrhagic event. At the final
follow-up contact 62 patients were taking aspirin and
none were receiving warfarin.
Reoperations
Twenty-five patients required 1 or more reoperations
or transcatheter pulmonary valve implantation. Fifteen
patients had reoperation on the neo-aortic valve: 13 for AI
(11 patients had valve replacement and 2 patients had valvery c January 2014
TABLE 1. Clinical profile and operative procedures
Variables Result
Age at surgery, median y (IQR) 34 (28-41)
25 38 (17.9)
26-35 76 (35.9)
36-45 70 (33.0)
>45 28 (13.2)
Men 140 (66.0)
Year
1994 52 (24.5)
1995-1999 95 (44.8)
2000-2004 65 (30.7)
Previous cardiac interventions
Previous aortic valve surgery 30 (14.2)
Previous mitral valve repair 1 (0.5)
Previous cardiac surgery (not listed above) 12 (5.7)
Any previous cardiac surgery 37 (17.5)
Clinical presentation
Timing of surgery
Elective 192 (90.6)
Same hospitalization 13 (6.1)
Urgent/emergent (<72 h from acute cardiac event) 7 (3.3)
Angina 39 (18.4)
NYHA functional class
I 41 (19.3)
II 135 (63.7)
III 26 (12.3)
IV 10 (4.7)
Left ventricular ejection fraction
60% 127 (60.0)
40%-59% 67 (31.6)
20%-39% 18 (8.5)
Congestive heart failure 34 (16.0)
Shock 0 (0.0)
Atrial fibrillation or flutter 1 (0.5)
Complete heart block/pacemaker 1 (0.5)
Syncope 19 (9.0)
Associated diseases
Hypertension 29 (13.6)
Hyperlipidemia 20 (9.4)
Chronic obstructive pulmonary disease 5 (2.3)
Previous stroke or transient ischemic attack 8 (3.8)
Diabetes mellitus 2 (0.9)
Endocarditis 15 (7.1)
Healed 13 (6.3)
Active 2 (0.9)
Pathology/pathophysiology
Mitral regurgitation 4 (1.9)
Aortic valve lesion
Stenosis 107 (50.4)
Insufficiency 77 (36.3)
Mixed lesion 28 (13.2)
Aortic valve pathology
Bicuspid 152 (71.7)
Other congenital 22 (10.3)
Prosthetic dysfunction 10 (4.7)
Tricuspid calcific 3 (1.4)
(Continued)
TABLE 1. Continued
Variables Result
Rheumatic 6 (2.8)
Miscellaneous 19 (9.0)
Operative data
Aortic annular enlargement 5 (1.4)
Pulmonary valve size, mean mm  standard deviation 27.2  1.4
Implantation technique
Inclusion or subcoronary 104 (49.0)
Root replacement 108 (50.9)
Surgical reduction of the aortic root
None 90 (42.7)
Aortic annulus 61 (28.9)
Sino-tubular junction 25 (11.9)
Aortic annulus þ sino-tubular junction 35 (16.6)
Replacement of ascending aorta 25 (11.8)
Mitral valve repair 4 (1.9)
Crossclamp time, median min (IQR) 123 (114-133)
Data are presented as n (%), unless otherwise indicated. IQR, Interquartile range;
NYHA, New York Heart Association.
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Drepair) and 2 for a subaortic false aneurysm (both repaired
with preservation of the pulmonary autograft). Twelve of
13 patients with AI that led to reoperation had AI before
the Ross procedure. AI before the Ross procedure
increased the risk of reoperation (hazard ratio [HR], 6.3;
95% CI, 1.3-29.4; P ¼ .02). All reoperations on the
pulmonary autograft were in men. Male sex was associated
with increased risk of reoperation (HR, 4.8; 95% CI,
1.6-14.4; P ¼ .005). Dilated aortic annulus index also
increased the risk of reoperation (HR, 1.408/mm; 95%
CI, 1.2-1.6; P<.001). The aortic annulus diameter cut-off
associated with increased reoperation on the neo-aortic
valve was 28 mm or 15 mm/m2. Figure 2 shows the
association between reoperation and the diameter of the
aortic annulus. The technique of implantation of the
pulmonary autograft had no effect on the risk of reopera-
tion. Table 2 shows the freedom from reoperation on the
neo-aortic valve for any cause at various times intervals
as well as in patients with preoperative AI that included
those with mixed lesions.
Eight patients required pulmonary homograft interven-
tion either combined with pulmonary autograft surgery
(2 patients) or in isolation (6 patients). Five patients under-
went pulmonary valve re-replacement and 3 underwent
transcatheter valve implantation. One patient required
reoperation on the pulmonary valve twice. There was no
association between any variable examined and pulmonary
homograft intervention.
Finally, 1 patient had isolated replacement of the ascending
aorta for aneurysm (the neo-aortic valve was competent),
and 3 patients underwent coronary artery bypass surgery.
There was no operative death or any serious perioperative
complication among the 25 patients who had reoperations
or catheter-based pulmonary valve implantation.ardiovascular Surgery c Volume 147, Number 1 87
TABLE 2. Freedom from morbid events at various time intervals
Freedom from event 5 y (95% CI) 10 y (95% CI) 15 y (95% CI) 20 y (95% CI)
All-cause mortality 98.6 (95.7-99.5) 97.5 (94.0-98.9) 93.6 (88.1-96.6) 93.6 (88.1-96.6)
Alive and reoperation-free on the AVor PV 93.7 (87.7-96.7) 90.4 (83.3-94.5) 84.4 (75.2-90.2) 77.9 (61.7-87.9)
Thromboembolism 99.1 (96.3-99.8) 98.6 (95.6-99.5) 98.6 (95.6-99.5) 96.8 (89.9-99.0)
Endocarditis No event 99.0 (96.0-99.7) 96.8 (92.4-98.7) 96.8 (92.4-98.7)
Reoperation on AV 97.6 (94.3-99.0) 96.5 (92.8-98.3) 93.0 (87.3-96.1) 81.8 (60.3-92.3)
Reoperation on patients with aortic insufficiency 95.2 (88.8-98.0) 94.1 (87.4-97.3) 87.3 (77.0-93.2) 75.5 (52.0-88.7)
Reoperation on PV No event 97.9 (94.5-99.2) 95.5 (90.5-97.9) 92.7 (85.6-96.4)
Aortic insufficieny* 93.1 (88.6-95.8) 90.3 (85.2-93.7) 88.7 (83.1-92.6) 62.6 (28.6-89.3)
PV dysfunctiony 93.0 (88.4-95.8) 84.8 (78.8-89.2) 74.6 (78.8-89.2) 53.8 (30.7-72.2)
Aortic root>44 mm 99.5 (96.6-99.9) 96.6 (92.5-98.5) 90.9 (84.2-94.9) 75.7 (42.5-91.4)
CI, Confidence interval; AV, aortic valve; PV, pulmonary valve. *Greater than mild. yModerate or severe pulmonary valve insufficiency and/or peak systolic gradient40 mmHg.
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DPathology of Explanted Pulmonary Valve Autograft
Eleven pulmonary valve autografts were explanted: 1
was normal (explanted 11 days after surgery) and 10 had
gross and histologic abnormality (explanted from 1 toFIGURE 1. A, Survival estimates of patients who underwent the Ross
procedure, including those who no longer had the pulmonary autograft
(black solid line) with 95% confidence limits (black dotted line) and that
of the general population matched for age and sex (dotted blue line).
B, Reoperation-free survival and the competing risks for any reoperation
on the pulmonary autograft or homograft and death.
88 The Journal of Thoracic and Cardiovascular Surge17 years [median, 8.7 years] after surgery). The cusps had
gross evidence of degenerative changes with thinning and
stretching of the cusps and elongation of the free
margins with prolapse. Four valves had cusp tears in the
commissural areas. Microscopy showed fragmentation of
the fibrous and elastic tissues and distortion of the normal
histology. Their basal region showed thickening due to
pannus.
Event-Free Survival and Late Functional Class
Figure 1, B, shows pulmonary autograft or pulmonary ho-
mograft reoperation-free survival and the competing risk of
reoperation and death. The estimates of reoperation-free
survival at various time intervals are shown in Table 2.
At the latest follow-up contact 202 patients were alive
and 191 still had their pulmonary autograft in place.
Overall, 180 (89%) patients were in New York Heart
Association functional class I, 18 (9%) in class II, and 4
(2%) in class III.
Echocardiographic Studies
AI. Twenty-six patients developed more than mild AI
(reported as mild to moderate or greater degree). Thirteen
patients with AI had reoperation because of symptoms
(3 patients), dilation of the aortic root (2 patients), or
dilation of the left ventricle (8 patients). In addition, 1
asymptomatic patient was scheduled for elective aortic
valve surgery at the time of the final follow-up contact
because of AI and impaired left ventricular systolic
function. Table 2 shows the freedom from AI greater than
mild at various time intervals. The following variables
increased the risk of late AI: preoperative AI (HR, 2.3;
95% CI, 0.9-5.5; P ¼ .06), aortic annulus 28 mm
(HR, 2.37; 95% CI, 1.02-5.52; P ¼ .04), and indexed
diameter of the aortic annulus (HR, 1.044/mm; 95%
CI, 1.006-1.085; P ¼ .02). Figure 3 shows the association
between preoperative aortic annulus diameter and the
development of AI.
Dilation of the pulmonary autograft. Progressive
dilation of the pulmonary autograft sinus defined asry c January 2014
FIGURE 2. A, Association between the probability of reoperation on the neo-aortic valve and the diameter of the aortic annulus (AA). The cut-off point
was28mm. B, Association between the probability of reoperation on the neo-aortic valve and the diameter of the AA adjusted for body surface area (BSA).
The cut-off point was at 15 mm/m2 (P ¼ .001). Shaded area represents 95% confidence intervals.
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increased to 39 to 44 mm in 24 patients, 45 to 49 mm in 7
patients, and>49 mm in 4 patients. Progression of aortic
sinus size was faster after the technique of root replacement
than after the technique of subcoronary implantation (0.149
 0.058 mm/year vs 0.122  0.060 mm/year; P ¼ .01).
Dilation of the neo-aortic root was associated with the
development of AI as seen in Figure 4. Table 2 shows the
freedom from dilation>44 mm of the pulmonary autograft
at various times intervals.
Pulmonary homograft dysfunction. Pulmonary valve
dysfunction was defined as pulmonary valve insufficiency
of moderate or severe degree and/or a peak systolic
gradient 40 mm Hg. Twenty-five patients developed
pulmonary homograft dysfunction but only 8 haveThe Journal of Thoracic and Cundergone reintervention. The remaining patients conti-
nue to be assessed for the development of symptoms
and/or right ventricular dilation/dysfunction to determine
the timing for reintervention. The freedom from reopera-
tion on the pulmonary homograft and the freedom
from pulmonary homograft dysfunction at various times
intervals is shown in Table 2. There were no predictors
of pulmonary valve dysfunction by multivariable analysis
and no statistically significant associations by univariable
analysis.
DISCUSSION
Aortic valve replacement is a palliative treatment for
aortic valve disease and the Ross procedure is no exception.
We have been examining a cohort of Ross patientsardiovascular Surgery c Volume 147, Number 1 89
FIGURE 3. A, Association between diameter of the aortic annulus (AA) index and the probability of postoperative development of aortic insufficiency
(P¼ .02). B, Association between the diameter of the AA and the probability of postoperative development of aortic insufficiency adjusted for body surface
area (BSA). Shaded area represents 95% confidence intervals.
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Dprospectively during the past 24 years to determine the
predictors of poor outcomes. Our data suggest that survival
after the Ross procedure during the first 2 decades of
observation is excellent, even including patients who had
reoperations as it was done in this report.
Mokhles and colleagues20 published a case-match study
of 253 patients who had isolated aortic valve replacement
with mechanical valve with a highly specialized anticoagu-
lation self-management operated on in Bad Oeynhausen,
Germany (mean age, 48 years; mean follow-up, 6.3 years)
and 253 patients who underwent the Ross procedure from
the German-Dutch Ross Registy (mean age, 47.3 years;
mean follow-up, 5.1 years) showing no difference in
survival up to 8 years.90 The Journal of Thoracic and Cardiovascular SurgeThe Ross procedure is a complex operation that
transforms aortic valve disease into combined aortic and
pulmonary valve disease. Therefore, if a young adult in
need for aortic valve replacement is willing to take warfarin
permanently, especially if able of self-monitoring the
anticoagulation, we believe that a mechanical valve is a
more reasonable alternative than the Ross procedure.
However, if anticoagulation is to be avoided the outcomes
of the Ross procedure should be compared with other types
of tissue valves. In our series of patients with the Ross
procedure the freedom from reoperation for any reason on
the pulmonary autograft was 81.8% at 20 years, the
freedom from reoperation on the pulmonary homograft
was 92.7%, and the combined risk of reoperation orry c January 2014
FIGURE 4. Association between dilatation of the neo-aortic root (AOSINUS) and the development of aortic insufficiency. Shaded area represents
95% confidence intervals.
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These outcomes are much better than those obtained after
aortic valve replacement with bioprosthetic aortic valves
or aortic valve homografts in patients of similar age.21-23
A randomized clinical trial on aortic valve replacement
with pulmonary autograft versus aortic homograft
conducted by Sir Magdi Yacoub23 showed a survival benefit
in patients who had the Ross at 10 years. Therefore, if
warfarin is to be avoided in young patients, particularly in
women during childbearing years, the Ross procedure is
an excellent alternative.24
Our results compare to those reported by Charitos and
colleagues from Lubeck, Germany.25 They examined a
cohort of 203 patients operated on from 1994 through
2001 with a mean age was 47.2 years, a minimum follow-
up of 10 years, and reported a freedom from reoperation
on the pulmonary autograft of 89.6% at 15 years.2 On
the other hand, Mokhles and colleagues4 from Rotterdam,
The Netherlands, reported freedom from reoperation on
the pulmonary autograft of only 51% at 18 years but their
patients had a mean age of 20.9 years and almost one-half
were aged<18 years, which is much lower than Charitos
and colleagues25 and our patients. The reasons for these
differences in outcomes are unclear. Probably patients’
age, aortic valve pathology, operative technique, and
surgeon’s experience played a role.10 In Mokhles’ series
of 161 patients,4 6 surgeons performed the operations
over a 22-year interval and used mostly the technique of
aortic root replacement. In the series reported by Charitos
and colleagues,25 203 patients were operated on over an
8-year interval and probably by a couple of surgeons
who used exclusively the technique of subcoronaryThe Journal of Thoracic and Cimplantation. As with any complex operative procedure,
repetition makes perfect and a certain volume of Ross
procedures is needed to develop expertise. In our series,
all operations were performed by 1 surgeon over a
15-year interval and both techniques of implantation were
used depending on the surgeon’s interpretation of the aortic
root pathology in relation to the normal pulmonary valve as
described in ‘‘Methods.’’ We did not find an association
between the implantation technique and the risk of reope-
ration on the pulmonary autograft. However, dilated aortic
annulus, preoperative AI, and male sex were associated
with increased risk of reoperation on the pulmonary
autograft. Several other investigators have identified
preoperative AI as a predictor of reoperation on the
pulmonary autograft.4-5,7,25 In the series described by
Charitos and colleagues,25 9 of 14 patients who required
reoperation on the pulmonary autograft had preoperative
AI and an aortic annulus>28 mm.
The main indication for reoperation on the pulmonary
autograft is the development of AI. In our patients the
freedom from AI greater than mild at 10, 15, and 20 years
was 90.3%, 88.7%, and 62.6%, respectively. AI appears
to be progressive after the Ross procedure. A dilated aortic
annulus (>28 mm in large patients or 15 mm/m2 in
smaller patients), and preoperative AI were independent
predictors of late AI. The technique of implantation of the
autograft was not associated with an increased risk of AI
but dilation of the aortic root was by univariable analysis.
Because the technique of aortic root replacement was
associated with greater degree of dilatation of the aortic
root than the subcoronary or inclusion techniques it is
possible that with a larger sample size the implantationardiovascular Surgery c Volume 147, Number 1 91
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postoperative AI in our series. We believe that both
techniques are useful and continue to use the inclusion tech-
nique when the aortic root is larger than the pulmonary root
and the technique of aortic root replacement when the aortic
root is too small or the coronary arteries’ orifices are close to
the annulus for safe subcoronary implantation. As we
mentioned previously27 we firmly believe that dilated aortic
annulus in patients with bicuspid aortic valve is a marker for
connective disorder that is probably present in the pulmo-
nary valve and we believe that the Ross should not be per-
formed in patients with aortic annulus index 15 mm/m2.
An Achilles’ heel of the Ross procedure is the pulmonary
homograft, which in our experience almost one-half of all
cases developed echocardiographic evidence of dysfunction
20 years after implantation. The freedom from pulmonary
homograft reintervention was high at 92.7% at 20 years
but many other patients had echocardiographic signs of
valve dysfunction and continue to be monitored to
determine the timing for reintervation. These findings are
consistent with those of other investigators.5,10,25 Young
age has been associated with increased risk of failure of
the pulmonary homograft,5,10 but it was not the case in
our series probably because our patients mean age was
34 years and we had none under 16 years of age.
Stulak and colleagues15 from the Mayo Clinic raised
concerns about the complexity and extensiveness of
reoperations on patients with failed Ross procedure. They
performed 144 procedures in 56 patients with failed Ross
and although they had only 1 operative death, 4 other
patients died within a mean follow-up of 8 months.15
Because most patients in that series had the initial operation
outside of the Mayo Clinic, the authors could not estimate
the overall burden of reoperation on patients who had the
Ross procedure. The fact is that in centers with large
experience with the Ross procedure reoperations carried a
very low operative mortality and morbidity.4,10,13,14,26
Mokhles and colleagues15 in Rotterdam, The Netherlands,
reoperated on 57 patients who had the Ross procedure
without operative mortality. We agree that reoperation for
failed Ross procedure is complex and often extensive but
it can be safely performed in experienced centers as it
was at Mayo Clinic.
Although our patients were prospectively followed and
valve function was sequentially assessed by echocardiogra-
phy in most patients, our study has several limitations. The
number of patients was relatively small and so was the
number of adverse events, limiting the value of multi-
variable models. Two different types of implantation
techniques were used and this further reduced the number
of patients in each subgroup to determine the importance
of the implantation technique on outcomes. In addition,
most of our patients had congenital aortic valve disease
and presented with stenosis, insufficiency or both lesions.92 The Journal of Thoracic and Cardiovascular SurgeFinally, all operations were performed by 1 surgeon and
the results may not be generalizable.
CONCLUSIONS
Aortic valve replacement with pulmonary autograft is a
complex and controversial operative procedure, yet we
believe that young adults who do not wish to have a
mechanical valve do very well after the Ross procedure as
long as their aortic annulus is not dilated.
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Discussion
Dr Nicholas T. Kouchoukos (St Louis, Mo). Dr David and
his colleagues have presented important outcomes data for
212 patients who underwent the Ross procedure and have
been followed for a median of 12.8 years and for up to 20 years.
The significant positive findings include excellent long-term
survival, essentially equal to that for an age- and sex-matched
population, and extremely low rates of thromboembolism and
endocarditis.
The concerning findings relate to the need for reoperation on the
neo-aortic valve and progression of both aortic regurgitation and
pulmonary allograft dysfunction, both stenosis and regurgitation,
particularly in the second decade of follow-up, irrespective of
the need for reoperation. Although 82% of patients had not
required reoperation on the neo-aortic valve at 20 years, only
63% were free of more than mild aortic regurgitation at that
time interval. Similarly, although 93% had not required reopera-
tion on the pulmonary allograft at 20 years, only 54% were free
of either moderate or severe pulmonary valve regurgitation or
stenosis>40 mm Hg.
These important observations suggest that freedom from
reoperation is an inadequate predictor of successful outcome
after the Ross procedure. The rates of deterioration in function
of both the autograft and the allograft were substantially
greater in the second decade of follow-up when compared
with the first, and one can only speculate, because these
were relatively young patients, what will happen in the third
decade and beyond. The effects of these changes in valvular
function on overall cardiac performance were not reported
in this study but are of obvious importance when one is
considering the Ross procedure for a particular patient,
especially one who is young.The Journal of Thoracic and CAnother important issue is the technique of implantation of the
autograft. Your study demonstrated no difference in the need for
reoperation for neo-aortic valve regurgitation between the root
replacement and the subcoronary or root inclusion techniques.
However, they were performed for somewhat different indications.
Despite this difference, dilation of the aortic sinuses occurred
with both techniques, although at a higher rate with the root
replacement technique. You have speculated in the past that
reimplantation of the autograft within the aortic root may be
associated with better long-term outcomes. However, this was
not observed in your presentation today. I have several questions
and I will ask them separately.
External reinforcement techniques have been proposed and
used in an attempt to prevent aortic root dilation and regurgitation.
Is there a role for these modifications to reduce the frequency of
regurgitation and reoperation?
Dr Tirone E. David (Toronto, Ontario, Canada). I don’t
believe so. I did in the past, but as my experience has increased
it doesn’t look like the operative technique plays a role in the
failure of this operation. It is more a marker that certain patients
have. I believe that dilation of the aortic annulus is a marker
for connective tissue disorder, and we should avoid the Ross
procedure in these patients.
I should add that in our failures due to aortic insufficiency
we could not save the aortic valve. They all showed signs of
degenerative disease, indicating that, indeed, they are predestined
to fail under adverse conditions such as the systemic circulation.
Dr Kouchoukos. Dilation of the aortic root is not an infrequent
late occurrence and was present in 35 patients in your series. At
10 years, 25% of patients had dilation>4.5 cm. Dissection of
the dilated aortic root has been reported in a small number of
patients. Would you consider elective operation in patients who
have enlarged aortic roots, and if so, at what diameter?
Dr David. I no longer offer the Ross procedure to patients who
have an annulus>28 mm. I tell them that in our hands the failure
rate is pretty high and we prefer to use an alternative. Having said
that, for female patients in their childbearing years who do not
want a mechanical valve, the Ross is a reasonable alternative.
Perhaps those patients should have some sort of external
reinforcement, preferably their own aortic root. But in our
experience it is not the sinus that is the problem. The pulmonary
cusps fail when placed in the aortic position, suggesting that
annuloaortic ecstasia is a marker for something more serious
than a dysfunctional aortic valve.
Dr Kouchoukos. What do you do for those patients who have
developed dilation, with root 4.5 cm or greater?
Dr David.Most had a bicuspid aortic valve and an incompetent
valve at the time of the operation.
Dr Kouchoukos. When would you recommend elective
replacement of the enlarged root to avoid problems with further
enlargement or dissection? Ever?
Dr David. We used the same criteria for native aortic root
aneurysm; that is, recommend surgery when the diameter exceeds
50 mm. I don’t know if it is justifiable to operate earlier because
most of our patients who developed dilation of the neo-aortic
root had a dilated aortic annulus and they may have degenerative
changes in the cusps of the autograft precluding an aortic valve
sparing operation.ardiovascular Surgery c Volume 147, Number 1 93
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the Ross operation? If so, who do you consider to be an ideal
patient?
Dr David. A man with aortic stenosis and an annulus<28 mm.
In women, to be quite honest, the lesion doesn’t matter. I don’t
know why. In the 98 women we studied all have normally func-
tioning pulmonary valves at 20 years. In other words, any women
or young male patients with aortic stenosis and normal annulus.
Dr Gosta B. Pettersson (Cleveland, Ohio). I would like to ask
you about your choice of procedure for the reoperations. I noticed
that you had done only 1 reimplantation procedure. In the Ross
community there is a lot of enthusiasm for doing the reimplanta-
tion procedure for the reoperation to salvage the autograft in aortic
position. You also mentioned that the leaflets are not normal. I
agree with your observation, and, as you know, I have favored
the Ross reversal procedure as a way to salvage the autograft. So
my first question: What is your choice of reoperation procedure?
I also have a follow up question: Would you consider earlier
reoperation to salvage more autograft valves in aortic position
by reoperating earlier to have a better chance of being able to do
reimplantation?
DrDavid. In our cohort most had abnormal cusps at reoperation
that precluded an aortic valve sparing. Often 2 or 3 cusps were
torn, and the histology showed scar tissue and fragmentation of
the elastic, suggestive of a degenerative process. And because
they all came from patients with bicuspid aortic valve with dilated
aortic annulus, I have to make the assumption that it is unwise to
repair the cusps to save the autograft.
My experience is largely with bicuspid aortic valves. I don’t
have experience with rheumatic disease. They may behave
differently
Dr Pettersson. What do you think about the reverse Ross
operation?
Dr David. I commend you on that, as I know you have done it.
The Ross operation is a difficult operation. To reverse it must be
even more difficult. I imagine it can be done and I will try the
next time I reoperate on a failed Ross.
DrD. CraigMiller (Stanford, Calif). I did not hear an answer to
Nick’s specific question. At what size Ross root aneurysms when94 The Journal of Thoracic and Cardiovascular Surgedone as a root replacement do you recommend operation?
Has anyone ever seen a Ross root aneurysm rupture or dissect?
Dr David. I have never seen it. A friend showed me images of a
Ross with a root of 55 mm and the valve was fairly competent
because he had reinforced both the annulus and the sinotubular
junction, but the sinus ruptured and he had to operate on the patient
as an emergency.
DrMiller.When do you reoperate on patients who are dilating?
Dr David.At 50 mm because I am hoping to save the valve, but
I didn’t in most of them because of bad cusps.
Dr Miller. In your analysis you had 2 techniques, an inclusion
sleeve and a root replacement. Nearly half of your patients were
done in the proper way, a subcoronary scallop, the real way that
this operation was originally introduced, and Hans Sievers has
the best results in the world. Was that variable inspected in terms
of your 2 dependent outcome variables?
Dr David. The technique was not a predictor of reoperation or
aortic insufficiency. It was in an early analysis, but as the follow-up
increased, it doesn’t seem to be a predictor.
There are certain technical details of root replacement that are
the reason other surgeons encounter dilation and failure. Suturing
the autograft, with an annulus that is entirely muscular, in a
supra-annular position is doomed to fail. That annulus is going
to dilate. If you put the muscle inside the outflow tract where
nature made the native aortic annulus, I don’t believe it dilates
very much. So perhaps the outcomes have more to do with how
you perform the root replacement than with the subcoronary
versus root replacement technique.
Dr Miller. Did you examine the third technique, something
short of root replacement, in your statistical analysis, freehand
scalloped? Did you examine all 3 ways?
Dr David. No. We grouped them together because I performed
root inclusion more often than subcoronary. If the root was dilated
enough, I simply opened the noncoronary sinus down to the
annulus, put the pulmonary inside the native root, and closed it
either primarily or with a patch. That is my root inclusion
technique. I only use the subcoronary position in patients with
an entirely normal aortic annulus and sino-tubular junction, which
very few patients have.ry c January 2014
